GlassScriptPhysician profile
Luis F Guerra
NPI 1295720787
$2,518.67
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.37 · 2022: $753 · 2023: $1,674 · 2024: $71.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,746.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $561.92 | 2022-2023 | Trelegy Ellipta, Nucala |
| Astrazeneca Pharmaceuticals LP | $349.72 | 2022-2023 | Breztri, Tezspire, Symbicort |
| Mylan Specialty L.P. | $302.53 | 2022-2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $236.26 | 2022-2023 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $221.39 | 2022-2023 | |
| Insmed, INC. | $184.42 | 2022-2023 | Arikayce |
| Inspire Medical Systems, INC. | $147.05 | 2023-2024 | Inspire |
| Novartis Pharmaceuticals Corporation | $123.51 | 2022-2023 | |
| Grifols USA, LLC | $72.82 | 2022-2023 | Prolastin-C Liquid |
| Covis Pharma Gmbh | $71.69 | 2022 | |
| Electromed, INC. | $47.72 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $39.38 | 2023 | Glassia |
| Baxter Healthcare | $32.81 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Amgen INC. | $27.46 | 2022-2023 | Tezspire |
| Boston Scientific Corporation | $24.24 | 2023 | Accolade Sr |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $19.37 | 2020 | |
| Jazz Pharmaceuticals INC. | $15.74 | 2023 | |
| Mallinckrodt Hospital Products INC. | $14.02 | 2023 | Acthar |
| Harmony Biosciences LLC | $13.65 | 2023 | Wakix |
| Shionogi INC | $12.97 | 2023 | Fetroja |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Guerra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.